S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

June 30, 2010

Conditions
Tobacco Dependence
Interventions
DRUG

S-Adenosyl-L-Methionine

800 mg dose per day for 8 weeks

DRUG

S-Adenosyl-L-Methionine

1600 mg per day for 8 weeks

OTHER

placebo

4 pills (2 in the AM and 2 in the PM) of placebos for 8 weeks

Trial Locations (2)

54601

Franciscan Skemp HealthCare, La Crosse

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Pharmavite LLC

INDUSTRY

lead

Mayo Clinic

OTHER